News

Perioperative MRI fails to reduce recurrence risk in women with ductal carcinoma in situ

Publish date: September 5, 2013

 

FROM THE ASCO BREAST CANCER SYMPOSIUM

Overall, 26% of the patients studied had breast MRI near the time of surgery, most commonly preoperatively, to assess disease extent.

Dr. Pilewskie and Dr. O’Day disclosed no relevant conflicts of interest.

Pages

Recommended Reading

Biennial vs annual mammography: How I manage my patients
MDedge ObGyn
Updated guideline urges discussion of breast cancer chemoprevention
MDedge ObGyn
PAM50 assay aids prediction of metastasis in early node-positive breast cancer
MDedge ObGyn
Do cosmetic breast implants hinder the detection of malignancy and reduce breast cancer–specific survival?
MDedge ObGyn
Racial discrepancy in breast cancer survival examined
MDedge ObGyn
Stem cell mutations in breast cancer may confer metastatic risk
MDedge ObGyn
Long-term CCB therapy linked to higher breast cancer risk
MDedge ObGyn
Long-term amenorrhea risk no higher for premenopausal breast cancer patients with BRCA mutations
MDedge ObGyn
No increase in cardiovascular risk seen after radiation therapy for DCIS
MDedge ObGyn
Most women misestimate their breast cancer risk
MDedge ObGyn